Congress temporarily suspends tariffs on imported formula to reduce cost
The Senate today passed and sent to the president for his signature the Formula Act (H.R. 8351), bipartisan legislation that would suspend tariffs on imported infant formula through 2022. The Food and Drug Administration has allowed formula imports to help address a U.S. formula shortage, but tariffs have increased the retail cost of these products. The Department of Health and Human Services offers a webpage to help health care providers and families locate formula.
Related News Articles
Headline
The Food and Drug Administration Oct. 29 issued a proposed rule to update infant formula nutrient requirements, the first such update since 1998. The proposal…
Headline
Extending Medicaid coverage by 12 months following childbirth increased use of postpartum care among mothers with pregnancy complications such as diabetes and…
Headline
A new blog, part of the Keeping Care Close to Home initiative, discusses how connected care networks are essential to sustaining rural maternal care. The blog…
Blog
When the American Hospital Association launched the Keeping Care Close to Home: Innovations in Rural Maternal Health project in 2025, we set out to understand…
Headline
The Department of Health and Human Services Oct. 9 announced the launch of its Newborn Essentials Support Toolkit Program, which, through partnership with the…
Headline
A study by the University of Minnesota Rural Health Research Center found that between 2007 and 2023, the percentage of midwife-attended births rose in…